Immediate Impact
9 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Shaoming Hu being referenced
The fibroblast growth factor receptor 2-mediated extracellular signal-regulated kinase 1/2 signaling pathway plays is important in regulating excision repair cross-complementary gene 1 expression in hepatocellular carcinoma
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shaoming Hu | 354 | 33 | 96 | 37 | 40 | 394 | |
| S. Marinoni | 376 | 22 | 176 | 25 | 24 | 398 | |
| R. Cosentino | 372 | 26 | 135 | 23 | 46 | 433 | |
| T. J. Kreidl | 379 | 25 | 73 | 26 | 35 | 390 | |
| Kefeng Tan | 329 | 36 | 177 | 23 | 25 | 372 | |
| Ramotholo Sefako | 342 | 41 | 68 | 21 | 31 | 350 | |
| Joy S. Nichols | 420 | 54 | 80 | 20 | 32 | 446 | |
| Roberto Viotti | 340 | 43 | 69 | 38 | 32 | 364 | |
| F. J. Kerr | 353 | 37 | 90 | 30 | 36 | 376 | |
| A. Spang | 360 | 16 | 143 | 20 | 42 | 387 | |
| F. Kiefer | 341 | 18 | 84 | 30 | 30 | 397 |
All Works
Login with ORCID to disown or claim papers
Loading papers...